LV
CordovaCann Corp.
LVRLF · OTC
$0.03 -3.56% (-$0.00)
1M -36.35%
Market Cap $4.86M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.04
25.7% upside
Current Price
$0.032
Undervalued Fair Value Overvalued
According to Bulios Fair Price, LVRLF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.35x
P/FCF 5.35x
P/E N/A
Growth
29 /100
Declining Rev. growth 1.77%
EPS growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Gross margin 13.34%
FCF margin 6.61%
Net margin 17.15%
Quality
21 /100
Poor ROIC 74.55%
Asset turnover 2.15x
ROA 36.81%
Debt
0 /100
High Current ratio 0.18x
Int. coverage -3.12x
Debt/Equity N/A
Stability
43 /100
Moderate Beta -0.18x
Profitable years 0
Rev. volatility 1.44%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LVRLF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Thomas Turner Jr.
Employees
78,574
Headquarters
Toronto
Upcoming events
02 NOV
Earnings
Upcoming earnings report